Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing

Human Mutation
Tuomas TikkanenT Soussi


Accurate annotation of genomic variants in human diseases is essential to allow personalized medicine. Assessment of somatic and germline TP53 alterations has now reached the clinic and is required in several circumstances such as the identification of the most effective cancer therapy for patients with chronic lymphocytic leukemia (CLL). Here, we present Seshat, a Web service for annotating TP53 information derived from sequencing data. A flexible framework allows the use of standard file formats such as Mutation Annotation Format (MAF) or Variant Call Format (VCF), as well as common TXT files. Seshat performs accurate variant annotations using the Human Genome Variation Society (HGVS) nomenclature and the stable TP53 genomic reference provided by the Locus Reference Genomic (LRG). In addition, using the 2017 release of the UMD_TP53 database, Seshat provides multiple statistical information for each TP53 variant including database frequency, functional activity, or pathogenicity. The information is delivered in standardized output tables that minimize errors and facilitate comparison of mutational data across studies. Seshat is a beneficial tool to interpret the ever-growing TP53 sequencing data generated by multiple sequencin...Continue Reading


Jun 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Shunsuke KatoChikashi Ishioka
Sep 24, 2009·Nature Reviews. Molecular Cell Biology·Mo Chen, James L Manley
Mar 20, 2010·Cold Spring Harbor Perspectives in Biology·Marie P Khoury, Jean-Christophe Bourdon
Feb 11, 2011·Human Mutation·Peter E M Taschner, Johan T den Dunnen
Oct 26, 2011·Nature Reviews. Genetics·Arleen D AuerbachChristine Van Broeckhoven
Feb 3, 2012·Leukemia·S PospisilovaEuropean Research Initiative on CLL (ERIC)
May 26, 2012·Proceedings of the National Academy of Sciences of the United States of America·Karolina EdlundT Soussi
Mar 1, 2014·Nature Reviews. Drug Discovery·Kian Hoe KhooDavid P Lane
Apr 29, 2014·FEBS Letters·Vladimir J N Bykov, K G Wiman
Mar 6, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sue RichardsACMG Laboratory Quality Assurance Committee
May 30, 2015·Cell Death and Differentiation·T Soussi, K G Wiman
Jun 8, 2015·Current Opinion in Oncology·Mandy L BallingerDavid M Thomas
Jan 24, 2016·Cold Spring Harbor Perspectives in Medicine·Sebastien M Joruiz, Jean-Christophe Bourdon
May 7, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey D KrimmelRosa Ana Risques
May 18, 2016·Nature Reviews. Genetics·Sara GoodwinW Richard McCombie
Jul 6, 2016·EBioMedicine·Lynnette Fernandez-CuestaPaul Brennan
Aug 3, 2017·The New England Journal of Medicine·Alan Trounson
Aug 18, 2017·Science Translational Medicine·Jillian PhallenVictor E Velculescu
Feb 23, 2018·Leukemia·J MalcikovaEuropean Research Initiative on Chronic Lymphocytic Leukemia (ERIC) — TP53 network

Related Concepts

TP53 protein, human
Computer Programs and Programming
Variation (Genetics)
Protein p53
Computational Molecular Biology
Twitter Messaging
Online Mendelian Inheritance In Man
Molecular Sequence Annotation
High-Throughput Nucleotide Sequencing

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.